Streetbeat News

Revenues

ABBV

BGNE

GILD

NVS

RHHBY

The FDA granted accelerated approval to BeiGene Ltd's Brukinsa, in combination with Roche Holdings AG's Gazyva, for adult patients with relapsed or refractory follicular lymphoma, marking its fifth indication in the U.S. This approval is based on the response rate and durability from the ROSEWOOD Phase 2 trial. Brukinsa's global sales reached $1.3 billion for the full year 2023, with peak annual sales estimated to be $3 billion to $4 billion. BGNE shares rose 0.94% following the announcement.

Portfolio Pulse from Vandana Singh

March 08, 2024 | 3:02 pm

BIG

Over the last three months, Big Lots (NYSE:BIG) has been evaluated by 5 analysts, showing a shift towards a more bearish outlook with 3 indifferent, 1 somewhat bearish, and 1 bearish rating recently. The average 12-month price target has been adjusted to $4.2, marking a 25.27% decrease from the previous $5.62. Analyst actions include adjustments to ratings and price targets, reflecting changing market conditions and company performance. Big Lots faces challenges with a -14.75% revenue decline, a high debt-to-equity ratio of 7.8, but shows strength in net margin (0.46%) and ROE (1.53%).

Portfolio Pulse from Benzinga Insights

March 08, 2024 | 3:01 pm

VLY

Valley National Bancorp (NASDAQ:VLY) has seen a diverse range of analyst ratings over the past quarter, with a recent shift towards a more bearish outlook. The average 12-month price target for VLY has been reduced by 10.47%, with current targets ranging from $8.00 to $12.00. Analyst actions include downgrades and adjustments to price targets, reflecting changing market dynamics and company performance. Valley Ntl's financial performance shows challenges in revenue growth, profitability, and debt management, with key metrics falling below industry averages.

Portfolio Pulse from Benzinga Insights

March 08, 2024 | 3:01 pm

BPOP

Recent analyst ratings for Popular Inc (NASDAQ:BPOP) show a positive trend, with upgrades and raised price targets suggesting optimism about the company's future performance. The average 12-month price target has increased to $95.75, up from $86.33. Despite facing challenges such as a revenue decline of -1.72% and a net margin below industry averages, Popular's return on equity (ROE) stands out positively. The company's market capitalization is below industry averages, indicating a smaller scale relative to peers.

Portfolio Pulse from Benzinga Insights

March 08, 2024 | 3:01 pm

NYCB

Recent analyst ratings for New York Community (NYSE:NYCB) show a predominantly neutral outlook, with 21 analysts offering varied perspectives. The average 12-month price target has been adjusted to $6.25, a significant drop from the previous $9.12. Analysts have adjusted their ratings and price targets, reflecting concerns over the company's financial performance, including a -15.74% revenue decline and challenges in debt management, net margin, and returns on equity and assets.

Portfolio Pulse from Benzinga Insights

March 08, 2024 | 3:00 pm

VNO

Over the past three months, 7 analysts have provided diverse opinions on Vornado Realty (NYSE:VNO), with recent ratings showing a shift towards a more bearish outlook. The average 12-month price target has been raised to $26.71, indicating an 8.27% increase from the previous target. Analyst actions include both downgrades and upgrades, reflecting varying perspectives on the company's performance. Vornado Realty, a REIT with properties in key U.S. cities, faces revenue challenges and a high debt-to-equity ratio, despite strong net margin and ROE.

Portfolio Pulse from Benzinga Insights

March 08, 2024 | 3:00 pm

HBAN

Analysts have updated their ratings and price targets for Huntington Bancshares (NASDAQ:HBAN), showing a diverse range of opinions. The average 12-month price target has increased to $14.95 from $12.80, indicating a positive outlook. The company's financial performance, however, shows challenges with a revenue decline of -9.33% and below-average profitability metrics such as net margin, ROE, and ROA. The debt-to-equity ratio is also higher than the industry average, suggesting financial risk.

Portfolio Pulse from Benzinga Insights

March 08, 2024 | 3:00 pm

SPY

In a CNN interview, Treasury Secretary Yellen stated that President Biden's top priority is addressing the high prices and cost of living affecting Americans. This indicates a focus on economic policies aimed at inflation control and financial relief for citizens.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 2:53 pm

SPY

In an MSNBC interview, U.S. Treasury Secretary Yellen highlighted the current state of the economy, noting very strong jobs growth. This statement can influence investor sentiment and market trends, particularly affecting indices and ETFs like SPY that track the overall U.S. market performance.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 2:40 pm

EPOW

Sunrise New Energy Co., Ltd. (EPOW) has secured a $14 million financing from China Everbright Bank, enhancing its liquidity for seamless production and delivery to major clients including CATL, BYD, and HiTHIUM.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 2:33 pm